筛选条件 共查询到53条结果
排序方式
Combined use of Lu-177-DOTATATE peptide receptor radionuclide therapy and fluzoparib for treatment of well-differentiated neuroendocrine tumors: A preclinical study

期刊: JOURNAL OF NEUROENDOCRINOLOGY, 2022; 34 (4)

Peptide receptor radionuclide therapy (Lu-177-DOTATATE) causes DNA strand breaks and has been validated for well-differentiated neuroendocrine tumor t......

JIF:3.267

Patients with non-functional metastatic G2 pancreatic neuroendocrine tumor benefit from palliative surgery: A 20-year single-center retrospective analysis

期刊: JOURNAL OF NEUROENDOCRINOLOGY, 2022; 34 (12)

Pancreatic neuroendocrine tumor (pNET) is the most common subset (31.5%) of gastroenteropancreatic neuroendocrine tumor in China. Based on real-world ......

JIF:3.267

The optimal duration of capecitabine plus temozolomide in patients with well-differentiated pancreatic NETs with or without maintenance therapy

期刊: JOURNAL OF NEUROENDOCRINOLOGY, 2022; 34 (6)

Background The optimal duration of capecitabine combined with temozolomide (CapTem) for metastatic pancreatic neuroendocrine tumours (PanNETs) remains......

JIF:3.267

2010 versus the 2000 consensus criteria in patients with normalised insulin-like growth factor 1 after transsphenoidal surgery has high predictive values for long-term recurrence-free survival in acromegaly

期刊: JOURNAL OF NEUROENDOCRINOLOGY, 2021; 33 (5)

The present study investigated the factors associated with recurrence during long-term follow-up in acromegaly and compared the recurrence rate betwee......

共53条页码: 1/4页15条/页